Collaborative Research Network Investigators > Clemens Scherzer, MD

Clemens Scherzer, MD

Coordinating Lead PI

Team Scherzer

PD Functional Genomics

Clemens Scherzer, MD, is a physician-scientist and professor of neurology at Harvard Medical School. He is founding director of the Center for Advanced Parkinson Research and the Precision Neurology Program, both at Brigham & Women’s Hospital.

His goal is to predict and prevent the progression of Parkinson’s disease. His laboratory aims to decipher how the human genome encodes billions of highly specialized brain cells and how glitches in this program drive disease and impact patients. Dr. Scherzer launched the Harvard Biomarkers Study, a discovery platform for personalized medicine and core cohort of the public-private Accelerating Medicines Partnership Parkinson’s Disease (AMP PD) program. He is a pioneer in precision neurology whose research has led to the discovery of genetic drivers, biomarkers, and therapeutic targets and is inspiring clinical trials.

Dr. Scherzer serves on the Scientific Advisory Board of the American Parkinson Disease Foundation and was recognized by the Dr. Paul Beeson and the George C. Cotzias Memorial Awards. His work has been featured in Science, Scientific American, Washington Post, US News & World Reports and NOVA Next.

Brigham and Women's Hospital at the Harvard Medical School | Cambridge, USA
COORDINATING LEAD PI

Clemens Scherzer, MD

Brigham and Women's Hospital at the Harvard Medical School

Clemens Scherzer, MD, is a physician-scientist and professor of neurology at Harvard Medical School. He is founding director of the Center for Advanced Parkinson Research and the Precision Neurology Program, both at Brigham & Women’s Hospital.

His goal is to predict and prevent the progression of Parkinson’s disease. His laboratory aims to decipher how the human genome encodes billions of highly specialized brain cells and how glitches in this program drive disease and impact patients. Dr. Scherzer launched the Harvard Biomarkers Study, a discovery platform for personalized medicine and core cohort of the public-private Accelerating Medicines Partnership Parkinson’s Disease (AMP PD) program. He is a pioneer in precision neurology whose research has led to the discovery of genetic drivers, biomarkers, and therapeutic targets and is inspiring clinical trials.

Dr. Scherzer serves on the Scientific Advisory Board of the American Parkinson Disease Foundation and was recognized by the Dr. Paul Beeson and the George C. Cotzias Memorial Awards. His work has been featured in Science, Scientific American, Washington Post, US News & World Reports and NOVA Next.